Admission Date:  [**2106-10-11**]              Discharge Date:   [**2106-10-20**]  Date of Birth:  [**2037-7-24**]             Sex:   M  Service: MEDICINE  Allergies: Sulfa (Sulfonamide Antibiotics) / Levaquin / Allopurinol / Rituxan / Droperidol / Doxycycline / Bacitracin  Attending:[**First Name3 (LF) 4891**] Chief Complaint: hypotension  Major Surgical or Invasive Procedure: Sinus debridment   History of Present Illness: 69 yo M w/ CLL, h/o Parkinson's Disease, recurrent pulmonary infections and chronic sinusitis who is s/p endoscopic sinus surgery (sinusectomy) on [**9-21**] to prevent recurrence of MRSA pneumonia.
On [**9-27**] he started to develop fevers, was seen by ENT on [**9-29**] and given inhaled vancomycin and betamethason as OR cultures were positive for MRSA.
He was then admitted from [**Date range (1) 83646**] and started on vancomycin with goal trough of 10.
During that admission his ANC dropped to 0 and was started on neuopgen by his oncologist, Dr. [**Last Name (STitle) 410**].
On [**10-8**] he underwent debridment by Dr. [**Last Name (STitle) 83647**] with minumal purulent discharge.
He was started on Cefepime to [**Last Name (un) **] converage grown on nasal swab for Pseudomonas on [**10-12**].
Past Medical History: Past Medical History: -CLL (dx [**1-10**]) s/p Rituximab, Fludarabine in [**2105**].
-Hypogammaglobulinemia (IgA, IgM) treated with IV Ig 2x/month (last [**2106-3-30**]) -Recurrent PNA with MRSA, Pseudomonas, M. gordonae (likely contaminant) -Bronchiectasis -Recurrent Sinusitis -Rectal ca in [**2084**] s/p resection, radiation, 5-FU -Parkinson's Dz dx [**2098**] -HTN   Social History: The patient is married, lives with his wife in [**Name (NI) **].
Pertinent Results: [**2106-10-10**] 11:55AM   GRAN CT-355* [**2106-10-10**] 11:55AM   PLT SMR-LOW PLT COUNT-86* [**2106-10-10**] 11:55AM   HYPOCHROM-1+ ANISOCYT-NORMAL POIKILOCY-NORMAL MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-NORMAL [**2106-10-10**] 11:55AM   NEUTS-1* BANDS-0 LYMPHS-98* MONOS-1* EOS-0 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 [**2106-10-10**] 11:55AM   WBC-35.5* RBC-2.76* HGB-8.4* HCT-25.1* MCV-91 MCH-30.5 MCHC-33.5 RDW-15.3 [**2106-10-11**] 12:45PM   PT-13.3 PTT-25.8 INR(PT)-1.1 [**2106-10-11**] 12:45PM   PLT SMR-LOW PLT COUNT-104* [**2106-10-11**] 12:45PM   HYPOCHROM-NORMAL ANISOCYT-NORMAL POIKILOCY-NORMAL MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-NORMAL [**2106-10-11**] 12:45PM   NEUTS-1* BANDS-0 LYMPHS-99* MONOS-0 EOS-0 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 [**2106-10-11**] 12:45PM   WBC-51.9* RBC-2.74* HGB-8.4* HCT-25.1* MCV-91 MCH-30.7 MCHC-33.6 RDW-15.9* [**2106-10-11**] 12:45PM   LACTATE-0.9 [**2106-10-11**] 12:45PM   estGFR-Using this [**2106-10-11**] 12:45PM   GLUCOSE-123* UREA N-17 CREAT-1.0 SODIUM-132* POTASSIUM-4.1 CHLORIDE-98 TOTAL CO2-24 ANION GAP-14 [**2106-10-11**] 01:30PM URINE  RBC-0 WBC-0 BACTERIA-MOD YEAST-NONE EPI-0 [**2106-10-11**] 01:30PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-25 GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2106-10-11**] 01:30PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.021 [**2106-10-11**] 08:25PM   PLT SMR-LOW PLT COUNT-84* [**2106-10-11**] 08:25PM   WBC-39.3* RBC-2.54* HGB-7.7* HCT-22.9* MCV-90 MCH-30.5 MCHC-33.8 RDW-15.9* [**2106-10-11**] 08:25PM   VANCO-9.5* [**2106-10-11**] 08:25PM   CK-MB-1 cTropnT-<0.01 [**2106-10-11**] 08:25PM   LD(LDH)-135 CK(CPK)-18* [**2106-10-11**] 08:25PM   GLUCOSE-155* UREA N-17 CREAT-1.1 SODIUM-132* POTASSIUM-3.5 CHLORIDE-97 TOTAL CO2-25 ANION GAP-14  [**2106-10-13**] 02:52AM BLOOD Gran Ct-1780* [**2106-10-12**] 04:00AM BLOOD Gran Ct-720* [**2106-10-10**] 11:55AM BLOOD Gran Ct-355* [**2106-10-13**] 12:03PM BLOOD TSH-2.5  [**2106-10-20**] 05:47AM BLOOD WBC-34.3* RBC-2.44* Hgb-7.4* Hct-22.5* MCV-92 MCH-30.4 MCHC-33.1 RDW-17.3* Plt Ct-54*  [**2106-10-20**] 05:47AM BLOOD Glucose-91 UreaN-16 Creat-1.1 Na-140 K-4.2 Cl-103 HCO3-32 AnGap-9  [**2106-10-11**] 11:30 am SWAB Site: SINUS **FINAL REPORT [**2106-10-14**]** GRAM STAIN (Final [**2106-10-11**]): 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES.
POTASSIUM HYDROXIDE PREPARATION (Final [**2106-10-17**]):       NO FUNGAL ELEMENTS SEEN.
Extensive adenopathy in the superior mediastinum, bilateral axillae, anterior mediastinum, tracheobronchial stations and the para-aortic space are again present: the largest right hilar node measures 18 x 26 mm compared to 13 x 21 mm on the prior study (3:46).
Conversely enlarged axillary and periaortic lymph nodes have decreased in size: A right axillary node measures 20 x 24 mm (2:20) compared to 22 x 32 mm on the prior study, the largest paraaortic posterior mediastinal node now measures 41 x 42 mm compared to 41 x 45 mm on the prior study (2:45).
The study is not tailored for subdiaphragmatic evaluation, only to confirm extensive para-aortic and retroperitoneal soft tissue masses which are incompletely visualized and stable perinephiric fat stranding.
Three new left upper lobe poorly defined nodules, in the setting of recent surgery could represent aspiration or infection.
He was empirically treated with Cefipime while pseudomonas cultures were speciated.
He was treated with cefipime and vancomycin, given history of MRSA sinusitis.
He was discharged with a PICC line and a plan for outpatient IV cefipime and Vancomycin to complete a total of 14 days of antibiotic therapy.
#: MICU course: On HD 4, he developed a fib with RVR and hypotension to SBP 70, he was transfered to the MICU where he was treated with fluid resussication and rate controlled with amiodarone and digoxin, he converted to sinus rhythm and both were discontinued and metoprolol 12.5mg [**Hospital1 **] was started.
# Afib: Following transfer from MICU, patient remained in sinus rhythm and was continued on metoprolol 12.5 mg TID.
On admission his neutrophil count was 790 and he received one dose of neuopgen to correct this.
Throughout admission, patient was maintained on home regimen of carbidopa/levodopa, Rasagiline 0.5 mg daily and Ropinirole 3 mg QID.
Medications on Admission: -Rasagiline 1 mg Tablet Sig: One (1) Tablet PO daily () as needed for parkinsons.
- Ropinirole 1 mg Tablet Sig: Three (3) Tablet PO QID (4 times a day).
-Amitriptyline 25 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
-Alprazolam 0.25 mg Tablet Sig: Three (3) Tablet PO QHS (once a day (at bedtime)).
-Nystatin 100,000 unit/g Cream Sig: One (1) Appl Topical [**Hospital1 **] (2 times a day) as needed for groin rash.
-Guaifenesin 600 mg Tablet Sustained Release Sig: Two (2) Tablet Sustained Release PO bid ().
-Psyllium Packet Sig: One (1) Packet PO TID (3 times a day) as needed for constipation.
-Vancomycin inhaled treatment (pt to take home medication) -Betamethasone Oral -Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for pain or fever.
-Carbidopa-Levodopa 25-100 mg Tablet Sig: Two (2) Tablet PO QAM (once a day (in the morning)) as needed for at 7 am.
- Carbidopa-Levodopa 25-100 mg Tablet Sig: 1.5 Tablets PO DAILY (Daily) as needed for 10:30 am.
Carbidopa-Levodopa 25-100 mg Tablet Sig: One (1) Tablet PO QPM (once a day (in the evening)) as needed for 2 pm.
-Carbidopa-Levodopa 25-100 mg Tablet Sig: One (1) Tablet PO QPM (once a day (in the evening)) as needed for 5:30 pm.
-Vancomycin in D5W 1 gram/200 mL Piggyback Sig: 250 ml Intravenous Q 12H (Every 12 Hours) for 16 days.
Disp:*80 grams* Refills:*0* -Carbidopa-Levodopa 25-100 mg Tablet Sig: 1.5 Tablets PO DAILY (Daily) as needed for 10:30 am.
Disp:*6 gram* Refills:*0* 3. acetaminophen 650 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for fever: do not exceed 4000mg in 24hrs 4. ropinirole 1 mg Tablet Sig: Three (3) Tablet PO QID (4 times a day).
5. amitriptyline 25 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
6. alprazolam 0.25 mg Tablet Sig: Three (3) Tablet PO QHS (once a day (at bedtime)).
Tablet(s) 7. nystatin 100,000 unit/g Cream Sig: One (1) Appl Topical [**Hospital1 **] (2 times a day): groin rash.
8. guaifenesin 600 mg Tablet Sustained Release Sig: Two (2) Tablet Sustained Release PO twice a day.
10. carbidopa-levodopa 25-100 mg Tablet Sig: Two (2) Tablet PO QAM (once a day (in the morning)).
11. carbidopa-levodopa 25-100 mg Tablet Sig: One (1) Tablet PO DAILY 2PM ().
12. carbidopa-levodopa 25-100 mg Tablet Sig: One (1) Tablet PO Daily 17:30.
13. carbidopa-levodopa 25-100 mg Tablet Sig: 1.5 Tablets PO DAILY 10:30.
14. betamethasone 0.6 mg/5 mL Solution Oral 15. rasagiline 0.5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
16. mupirocin 2 % Ointment Sig: One (1) Appl Topical every [**4-13**] hours: 3 inches of Mupirocin mixed in saltaire bottle (420mL), use 2 squirts in each nostril .
17. metoprolol tartrate 25 mg Tablet Sig: 0.5 Tablet PO TID (3 times a day).
Outpatient Lab Work Please check CBC with differential and fax to Dr. [**Last Name (STitle) 724**] at [**Telephone/Fax (1) 11959**], and Dr. [**Last Name (STitle) 410**] at [**Telephone/Fax (1) 21962**]   Discharge Disposition: Home With Service  Facility: Northeast Home care  Discharge Diagnosis: Primary diagnosis Pseudomonas sinusitis  Secondary diagnoses: Paroxsymal Atrial fibrillation CLL (dx [**1-10**]) s/p Rituximab, Fludarabine in [**2105**].
Hypogammaglobulinemia (IgA, IgM) treated with IV Ig 2x/month (last [**2106-3-30**]) Recurrent PNA with MRSA, Pseudomonas, M. gordonae (likely contaminant) Bronchiectasis Recurrent Sinusitis Rectal CA in [**2084**] s/p resection, radiation, 5-FU Parkinson's Dz dx [**2098**]  Discharge Condition: Mental Status: Clear and coherent.
You were treated with IV antibiotics with good result.
Your heart rhythm returned to [**Location 213**] and you were started on metoprolol to prevent return of atrial fibrillation.
We recommend that you follow up with your primary care doctor to discuss the length of treatment with metoprolol.
We made the following changes to your medications: - Start Metoprolol 12.5mg three times per day - Start IV Cefipime three times per day - Start IV vancomycin twice per day  Followup Instructions: Please call Dr. [**First Name (STitle) **] from Ear Nose and Throat to arrange follow up for this Thursday ([**10-21**]) or Friday ([**10-22**]).
